Purpose: Hallux valgus (HV) is a common foot disorder with a clinically suspected genetic predisposition, but virtually no formal genetics assessment. We have recently shown in the Framingham Foot Study that this condition is highly heritable. We report the first genome-wide association study of HV using data from the Johnston County Osteoarthritis Project (JoCo OA), a study of OA in a North Carolina county. Methods: The sample consisted of 916 Caucasian adults (mean age 62.1 [SD 9.0]; 39% men) participating in the first follow-up (1999)(2000)(2001)(2002)(2003)(2004) or new enrollment cohort (2003)(2004) of JoCo OA who contributed blood for genetic analysis and had data on HV. HV (present/absent) was determined in the standing position by trained examiners as 'present' when the angle between the longitudinal axes of hallux and first metatarsal was >¼15 degrees and otherwise defined as 'absent'. Genotyping was performed with Illumina 1M Duo and imputation to w 2.5M SNPs done with HapMap. Association analyses adjusted for age, sex, BMI, and recruitment site were performed using logistic regression with Generalized Estimating Equations on 2,540,970 SNPs after data cleaning and imputation . Results: HV was present in 61.8% of the sample. Thirteen SNPs within the MYH13 gene locus were associated with HV at genome-wide levels of statistical significance (P < 5x10E-8). Other genes located near suggestively associated SNPs include genes previously associated with OA (A2BP1 and GDF5). Among genes suggestively associated with HV, genes involved in neurocellular development and implicated in neuropathology (DISC1, NEFL, CNTN5) were well represented. Conclusion: HV is highly heritable and associated with several SNPs that have been identified with OA in other cohorts. Further analysis of these SNPs, validation in another cohort, and meta-analysis will help assess the replicability of these findings and the significance of these observations. That some of these SNPs have been associated with OA supports the inclusion of HV as a part of the generalized OA phenotype.
Purpose: Hallux valgus (HV) is a common foot disorder with a clinically suspected genetic predisposition, but virtually no formal genetics assessment. We have recently shown in the Framingham Foot Study that this condition is highly heritable. We report the first genome-wide association study of HV using data from the Johnston County Osteoarthritis Project (JoCo OA), a study of OA in a North Carolina county. Methods: The sample consisted of 916 Caucasian adults (mean age 62.1 [SD 9 .0]; 39% men) participating in the first follow-up (1999) (2000) (2001) (2002) (2003) (2004) or new enrollment cohort (2003) (2004) of JoCo OA who contributed blood for genetic analysis and had data on HV. HV (present/absent) was determined in the standing position by trained examiners as 'present' when the angle between the longitudinal axes of hallux and first metatarsal was >¼15 degrees and otherwise defined as 'absent'. Genotyping was performed with Illumina 1M Duo and imputation to w 2.5M SNPs done with HapMap. Association analyses adjusted for age, sex, BMI, and recruitment site were performed using logistic regression with Generalized Estimating Equations on 2,540,970 SNPs after data cleaning and imputation . Results: HV was present in 61.8% of the sample. Thirteen SNPs within the MYH13 gene locus were associated with HV at genome-wide levels of statistical significance (P < 5x10E-8). Other genes located near suggestively associated SNPs include genes previously associated with OA (A2BP1 and GDF5). Among genes suggestively associated with HV, genes involved in neurocellular development and implicated in neuropathology (DISC1, NEFL, CNTN5) were well represented. Conclusion: HV is highly heritable and associated with several SNPs that have been identified with OA in other cohorts. Further analysis of these SNPs, validation in another cohort, and meta-analysis will help assess the replicability of these findings and the significance of these observations. That some of these SNPs have been associated with OA supports the inclusion of HV as a part of the generalized OA phenotype. Purpose: In osteoarthritis (OA), articular chondrocytes undergo phenotypic change and acquire the ability to overexpress matrix-degrading genes. Our previous studies have shown that the increased expression of catabolic genes, including MMPs, ADAMTS4 and IL1B, in OA chondrocytes correlates with demethylation of specific CpG sites in their promoters. Further, we have shown that E74-like factor 3 (ELF3) protein levels are increased in OA cartilage, and that ELF3 contributes to matrix metalloproteinase 13 (MMP13) expression in chondrocytes, hence suggesting its involvement in cartilage degradative processes. The aims of this study were 1) to analyze the ELF3 relative expression and promoter methylation status in non-OA and OA human primary chondrocytes, and 2) to determine whether ELF3 transcriptional activation is affected by its promoter methylation status in chondrocytes in vitro. Methods: ELF3 gene expression and the methylation status of its proximal promoter were assessed by RT-qPCR and bisulfite sequencing, respectively, in isolated healthy (#NOF) and OA human chondrocytes. Two ELF3 promoter constructs (spanning -622/+163 bp and -327/+163 bp) containing 20 and 18 CpG sites, respectively, were generated by PCR and cloned into a CpG-free reporter vector. The ELF3 reporter constructs were left untreated or treated with M.SssI DNA methyltransferase, to methylate all of the CpG sites in the promoter region. Each non-methylated and methylated reporter construct was transfected into C28/I2 chondrocytes, and the promoter activities were analyzed by reporter assays. In addition, CpG sites in the -622/+163 construct were methylated in various patterns using M.SssI, HhaI and HpaII methyltransferases, and the promoter activities were analyzed as described. Results: RT-qPCR analysis revealed increased ELF3 expression in OA chondrocytes (3-fold) compared to non-OA chondrocytes. Bisulfite sequencing showed increased CpG methylation of the ELF3 proximal promoter in OA chondrocytes (Figure 1) . Methylation treatment suppressed the activities of the -622/+163bp and -322/+163bp ELF3 promoter constructs (11.8 and 8.4-fold, respectively). Further, total or partial CpG methylation of the -622/+163 bp reporter construct by M.SssI, HhaI or HpaII lead to a significant suppression of the ELF3 promoter activity. Conclusions: We here report that the ELF3 gene expression is increased in OA chondrocytes compared to non-OA chondrocytes, and that the CpG methylation status of the ELF3 proximal promoter is increased in OA chondrocytes. On the other hand, in vitro CpG methylation of ELF3 reporter constructs decreased the ELF3 promoter activities. The latter discrepancy suggests that the contribution of CpG methylation to the ELF3 promoter transcriptional control may depend upon the methylation status of specific CpG site/s, and that the same events that may block ELF3 transcriptional repressors may also affect the actions of activators of the ELF3 promoter. Further investigation is needed to elucidate the relative contribution of the CpG methylation status to the ELF3 transcriptional control in OA chondrocytes, and to define the transcriptional modulators affected by the methylation status of the ELF3. Abstracts / Osteoarthritis and Cartilage 20 (2012) S54-S296 S194
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